Reperfusion Brain Injury Focus on Cellular Bioenergetics

Total Page:16

File Type:pdf, Size:1020Kb

Reperfusion Brain Injury Focus on Cellular Bioenergetics Reperfusion brain injury Focus on cellular bioenergetics Svetlana Pundik, MD, ABSTRACT MS Energy production for the maintenance of brain function fails rapidly with the onset of ischemia Kui Xu, PhD and is reinstituted with timely reperfusion. The key bioenergetic organelle, the mitochondrion, is Sophia Sundararajan, strongly affected by a cascade of events occurring with ischemia and reperfusion. Enhanced MD, PhD production of reactive oxygen species, disruption of calcium homeostasis, and an inflammatory response are induced by reperfusion and have a profound effect on cellular bioenergetics in re- versible stroke. The impact of perturbed bioenergetics on cellular homeostasis/function during Correspondence & reprint requests to Dr. Pundik: and after ischemia are discussed. Because mitochondrial function can be compromised by de- [email protected] rangements at more than one of the susceptible sites on this organelle, we propose that a combi- nation therapy is needed for the restoration and maintenance of cellular bioenergetics after reperfusion. Neurology® 2012;79 (Suppl 1):S44–S51 GLOSSARY ATP ϭ adenosine triphosphate; DAMP ϭ danger-associated molecular pattern molecule; MPTP ϭ mitochondrial permeability transition pore; ROS ϭ reactive oxygen species; SAINT ϭ Stroke-Acute Ischemic NXY Treatment; SEF ϭ secondary energy failure; STAIR ϭ Stroke Therapy Academic Industry Roundtable; TNF␣ ϭ tumor necrosis factor-␣. Stroke is a complex and dynamic disease of the brain that rates fourth in mortality and first in disability in the United States. The brain has certain unique physiologic properties that make it extremely sensitive to the loss of blood flow. In general, the energy demands of the brain are high, requiring a continual supply of oxygen and its principal substrate, glucose, mainly from the blood. Occluding blood flow to the brain disrupts the delicate balance between the energy generated by glucose oxidation and energy needed for cell processes, which leads to a rapid loss of function and cell homeostasis. The imbalance of the brain bioenergetics induced by the loss of blood flow has been shown to lead to cellular infarction of all brain cells, including neurons, astrocytes, endothelial cells, oligodendrocytes, and subpopulations of these cells. Conversely, a pronounced deranged cellu- lar milieu resulting from ischemia elicits a plethora of reactions upon re-establishment of reflow. It is increasingly evident that many of the events center on the neurovascular unit, a functional composite of microvessels, pericytes, astrocytes, neurons, axons, and other support- ing cells such as microglia and oligodendrocytes. Although many of the reflow-induced events may be pathologic and their prevention potentially beneficial, it is our contention that the status of cellular bioenergetics is the major determinant of many of the pathophysiologic sequelae manifested in the neurovascular unit and therefore is fundamental to the outcome for the tissue, following reversible focal ischemia. In the past 50 years, basic science investigations first established that loss of blood flow to the brain resulted in rapid failure of cell bioenergetics, followed by an ever-increasing list of cellular perturbations. A schematic of ischemia-induced events is shown in figure 1. Rapid energy depletion reflects very low energy reserves within the brain, a high metabolic rate, and almost a total reliance on glucose oxidation for energy production. The ischemic cascade is initiated during ischemia. Ischemia depletes adenosine triphosphate (ATP) within minutes, leading to a failure of a From Case Western Reserve University (S.P., K.X., S.S.), Cleveland Veterans Affairs Medical Center (S.P.), and University Hospitals Case Medical Center (S.S.), Cleveland, OH. Go to Neurology.org for full disclosures. Disclosures deemed relevant by the authors, if any, are provided at the end of this article. S44 © 2012 American Academy of Neurology Figure 1 A schematic of key ischemia and reperfusion-induced processes leading to mitochondrial dysfunction and cell death multitude of energy-dependent cellular pro- ration of ischemia is a major determinant of the cesses critical to cellular homeostasis and brain magnitude of the pathophysiologic response, function.1–3 Parenthetically, most physiologic and time of the ischemic episode cannot be processes within the cell are either directly or in- overemphasized when discussing the outcome directly impacted by the loss of energy. The im- following stroke. mediate consequence of diminished energy Restoring blood flow to the brain elicited reserves is perturbation of membrane electro- multiple cellular and physiologic events, and chemical gradients, leading to depolarization. it was initially expected that reperfusion The influx of sodium, calcium, and chloride would simply be a reversal of the ischemia- into the intracellular space and potassium efflux induced disruption of the cellular milieu to result in increased intracellular water and cyto- re-establish function; however, this clearly is toxic brain edema.4 Depolarization increases in- not the case. Experimental evidence shows tracellular calcium, activating transcription that reperfusion triggers a set of unique, po- factors, phospholipases, endonucleases, and pro- tentially pathologic events including, for ex- teases and leading to deranged intracellular sig- ample, increased prostaglandin synthesis, naling, compromised cellular function, and loss elevated production of second messengers, in- of structural integrity.5 Depolarization also trig- flammation, and mitochondrial dysfunction, gers excessive release of glutamate, which results as indicated by elevated reactive oxygen spe- in an increased activation of glutamate receptors cies (ROS) and the opening of the mitochon- and an additional influx of calcium, accentuat- drial permeability transition pore (MPTP).9–13 ing cellular injury.6 The cascade of ischemic It is our contention that if the bioenergetics of events disrupts cellular homeostasis, and if not the brain are not normalized, the tissue will reversed, it causes tissue necrosis. If reflow is ini- die, and rectifying the other potentially tiated in a timely fashion, however, tissue recov- pathogenic events would be of little value. In ers. Early reperfusion with thrombolytics is the spite of the collapse of cellular homeostasis only US Food and Drug Administration–ap- during ischemia, the brain has the capacity to proved treatment for ischemic stroke.7,8 The du- re-establish energy metabolism and then to Neurology 79 (Suppl 1) September 25, 2012 S45 counteract the ischemia-induced events, lead- depletion and neuronal death during reperfu- ing to the restoration of function if reperfu- sion.16 Of interest, there is evidence of selec- sion occurs within certain time constraints. In tive delayed neuronal death phenomenon this context, it has been a challenge to deter- following cardiac arrest and resuscitation in mine which of the reflow events unrelated to humans.17 bioenergetics are pathologic, vs those that are In the second model, delayed secondary merely epiphenomenal. loss of bioenergetics (i.e., SEF) and cell death The central event to the evolution of irre- have been demonstrated in a focal model of versible mitochondrial injury appears to be reversible ischemia. The middle cerebral ar- the formation of MPTP.14 The MPTP, when tery in the rat was transiently occluded for 2 open, becomes permeable to ions and large hours, and energy stores of the ischemic core Ͻ molecules ( 1,500 Kd), disrupting the mito- and surrounding region (i.e., penumbra) were chondrial electrochemical gradient necessary variably depleted.18,19 Upon reperfusion, the to drive oxidative phosphorylation and ATP concentration of ATP in the cerebral cortex 10 synthesis. Although the MPTP is present in was transiently restored, only to fail several the normal brain and subtle reversible open- hours later (figure 2). In contrast, levels of ings of the pore are detectable even at the early glucose remain elevated, as levels of ATP de- stages of reperfusion, evidence suggests that creased, indicating the ATP effect was unre- the massive pore opening is the final irrevers- lated to changes in substrate availability. 15 ible step in the evolution of brain damage. These findings have been confirmed by sev- From the literature, there is evidence to sug- eral laboratories, which also found that the gest that mitochondrial dysfunction is associ- magnitude of the changes was more pro- ated with free radical formation, calcium nounced in the ischemic core than in the pen- overload, and inflammation during reflow, umbra.18,19 Noticeably, there was a complete which may contribute to the massive opening restoration of blood flow in both models of of the MPTP.11 These will be discussed below ischemia, suggesting that deprivation of glu- with the idea that concerted interventions in cose and oxygen was unlikely to be the precip- these factors may produce neuroprotection. itating cause of secondary energy depletion One factor that generally has been overlooked and cell death. is that partial recovery of bioenergetics of the tissue is transiently evident upon reperfusion, From the experimental results on ischemic and if the compromised energy metabolism and reperfusion events, our current knowl- persists, secondary energy failure (SEF) is edge of the pathophysiology of ischemia can manifested and cell death ensues. be summarized as follows. First, cessation of Evidence for the existence of reflow- mitochondrial
Recommended publications
  • Noninvasive Evaluation of Myocardial Ischemia and Left Ventricular Function
    Linköping University Medical Dissertations No. 1109 Noninvasive Evaluation of Myocardial Ischemia and Left Ventricular Function Eva Maret Division of Cardiovascular Medicine Department of Medical and Health Sciences Linköping University, Sweden Linköping 2009 Eva Maret, 2009 Cover picture/illustration: William Björklund Published articles have been reprinted with the permission of the copyright holder. Printed in Sweden by LiU-Tryck, Linköping, Sweden, 2009 ISBN 978-91-7393-675-0 ISSN 0345-0082 To Martin and John! Somewhere over the rainbow Way up high, There's a land that I heard of Once in a lullaby. Somewhere over the rainbow Skies are blue, And the dreams that you dare to dream Really do come true. From “The Wizard of OZ”, music by Harold Arlen and lyrics by E.Y. Harburg CONTENTS POPULÄRVETENSKAPLIG SAMMANFATTNING ................................................................ 7 LIST OF PUBLICATIONS .......................................................................................................... 9 INTRODUCTION ....................................................................................................................... 13 Coronary Artery Disease ........................................................................................................ 13 Coronary flow, resistance and flow reserve ........................................................................... 14 Coronary atherosclerosis and myocardial infarction .............................................................. 15 Left ventricular function
    [Show full text]
  • Chapter 1: Stroke and Neuroprotection 1 – 21
    DEVELOPMENT OF NOVEL THERAPEUTICS FOR STROKE: PRECLINICAL INVESTIGATIONS OF OSTEOPONTIN AND 3-IODOTHYRONAMINE By Kristian Paul Doyle A DISSERTATION Presented to the Department of Molecular Microbiology & Immunology at the Oregon Health & Science University in partial fulfillment of the requirements for the degree of Doctor of Philosophy 1 CONTENTS List of Figures v List of Tables ix Acknowledgements x Preface xi Abstract xii List of Abbreviations xv Chapter 1: Stroke and Neuroprotection 1 – 21 1.1 Introduction 2 1.2 Brief History of Stroke 2 1.3 Stroke Pathophysiology 4 1.4 Neuroprotection 17 1.5 Ischemic Preconditioning 19 1.6 Research Goal 21 Chapter 2: Osteopontin 22-86 2.1 An Introduction to OPN 23 2.2 The Structure of OPN 23 2.3 OPN, Integrins and Survival Signaling 25 2.4 OPN and Ischemic Injury 27 2.5 Preclinical Development of OPN 33 2.6 Optimizing Delivery 33 2 2.7 Improving the Potency of OPN 36 2.8 Identifying the Regions of OPN required for Neuroprotection 36 2.9 Hypothesis 37 2.10 Research Design 38 2.11 OPN has neuroprotective capability in vivo and in vitro 40 2.12 The mechanism of neuroprotection by OPN 51 2.13 OPN can be delivered to the brain by intranasal administration 56 2.14 Enhancing the neuroprotective capability of OPN 60 2.15 Peptides based on the N and C terminal fragment of thrombin cleaved OPN are neuroprotective 65 2.16 The C terminal peptide requires phosphorylation to be neuroprotective while the N terminal peptide does not require phosphorylation 70 2.17 Dose response and time window of NT 124-153 71 2.18
    [Show full text]
  • College Catalog 2011–2012
    1 College Catalog 2011–2012 - BOSTON | WORCESTER | MANCHESTER, NH This catalog is intended to provide working guidelines and descriptions of the general and academic policies of the College applicable to students. It is not intended and cannot be Massachusetts College of Pharmacy and Health Sciences construed as a contract or guaranty of any kind, express or implied, and the College may 179 Longwood Avenue, Boston, Massachusetts 02115 change, delete or add to these guidelines unilaterally in its sole discretion and without notice. The College also reserves the right to determine the applicability of any policy to a particular Telephone 617.732.2800; students outside Massachusetts and within the continental United situation or set of circumstances and to depart from the guidelines contained herein in States may call toll free 1.800.225.5506. Non-Discrimination Policy a given case. This catalog supersedes any previous catalog, policies or practices relating It is the policy and commitment of Massachusetts College of Pharmacy and Health Sciences 2 to students. It is the responsibility of the students to know and understand the College’s 3 not to discriminate on the basis of race, religion, color, age, sexual orientation, sex, sexual policies. The College may from time to time acquire or develop new programs, or expand its identity, disability, veteran status, marital status or national origin in its educational pro- offerings in other locations, including distance learning programs, and the guidelines in this grams, activities, admissions or employment policies and to actively comply with the require- ments of Federal Executive Orders 11246 and 11375 as amended; the Civil Rights Act of catalog shall apply to all such programs and locations.
    [Show full text]
  • Ischemia and Reperfusion Injury: When Cells Almost Die
    Peer Reviewed CE Article #1 Ischemia and Reperfusion Injury: When Cells Almost Die Amy N. Breton, CVT, VTS (ECC) Veterinary Emergency and Specialty Center of New England Waltham, Massachusetts schemia is defined as inadequate blood supply to a part ing energy for metabolism within cells.3 One of the fastest of the body, usually caused by partial or total block- ways that ATP is produced is by oxidative phosphorylation, age of an artery. Reperfusion injury occurs when tissue which, as the name implies, requires oxygen.3 Despite the I 3 perfusion and oxygenation are restored to an area that has importance of ATP, cells do not stockpile ATP. They only been affected by an ischemic event. make what they need for a particular time. When ischemia Ischemia/reperfusion (I/R) injury is a complex cascade occurs, oxygenation of cells ceases, resulting in anaerobic of events resulting in devastating effects on the body, ATP production, which is less efficient.3 sometimes including death. Despite more than 70 years of When oxygen becomes unavailable, cells begin anaero- research, I/R injury is not fully understood. Events such as bic glycolysis. This process can be a lifesaving way for cells gastric dilatation–volvulus (GDV), mesenteric torsion, or to obtain energy; however, it is extremely wasteful. During strangulation of a limb can lead to I/R injury. It is important anaerobic glycolysis, pyruvic acid and hydrogen atoms for all veterinary personnel to understand I/R injury so that combine with nicotinamide adenine dinucleotide (NAD) treatment and prevention can begin as early as possible. to form NADH and H+.3 If the buildup of NADH and H+ within cells becomes too great, the anaerobic process stops, The Ischemic Cascade terminating energy production.3 However, NADH and H+ The chain of events involved in I/R injury can be broken combine to form lactic acid, which diffuses from cells rap- down into the ischemic cascade (BOX 1) and reperfusion idly so that the process can continue.3 Although this is not injury (BOX 2).
    [Show full text]
  • 2020 Vascular Neurology CERT Content Specifications
    SUBSPECIALTY CERTIFICATION EXAMINATION IN VASCULAR NEUROLOGY 2020 Content Blueprint (December 16, 2019) Number of questions: 200 questions Percent 01. Basic science aspects of vascular neurology 4-6% 02. Risk factors and epidemiology 8-12% 03. Clinical features of cerebrovascular diseases 8-12% 04. Evaluation of the patient with cerebrovascular disease 13-17% 05. Causes of stroke 18-22% 06. Complications of stroke 4-6% 07. Treatment of patients with stroke 28-32% 08. Recovery, regenerative approaches, and rehabilitation 4-6% TOTAL 100% Note: A more detailed content outline is shown below 2020 ABPN Content Specifications Page 1 of 15 Posted January 6, 2020 Certification in Vascular Neurology SUBSPECIALTY CERTIFICATION EXAMINATION IN VASCULAR NEUROLOGY 2020 Content Outline Content Areas 01. Basic science aspects of vascular neurology A. Vascular neuroanatomy 1. Extracranial arterial anatomy 2. Intracranial arterial anatomy 3. Collaterals 4. Alterations of vascular anatomy 5. Venous anatomy 6. Spinal cord vascular anatomy 7. Specific vascular-brain anatomic correlations 8. End vessel syndromes B. Stroke pathophysiology 1. Cerebral blood flow a. Vascular smooth muscle control b. Vasodilation and vasoconstriction c. Autoregulation d. Vasospasm e. Rheology f. Blood flow in stroke 2. Blood-brain barrier in stroke 3. Coagulation cascade a. Clotting factors b. Platelet function c. Endothelium function d. Biochemical factors 4. Metabolic and cellular consequences of ischemia a. Ischemic cascade b. Reperfusion changes c. Electrophysiology d. Gene regulation 5. Inflammation and stroke 6. Brain edema and increased ICP a. Secondary effects 2020 ABPN Content Specifications Page 2 of 15 Posted January 6, 2020 Certification in Vascular Neurology 7. Restoration and recovery following stroke 8.
    [Show full text]
  • Reduced Susceptibility to Ischemic Brain Injury and N-Methyl-D-Aspartate-Mediated Neurotoxicity in Cyclooxygenase-2-Deficient Mice
    Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice Costantino Iadecola*†, Kiyoshi Niwa*, Shigeru Nogawa*, Xueren Zhao*, Masao Nagayama*, Eiichi Araki*, Scott Morham‡, and M. Elizabeth Ross* *Center for Clinical and Molecular Neurobiology, Department of Neurology, University of Minnesota Medical School, Minneapolis, MN 55455; and ‡Myriad Genetics, Salt Lake City, UT 84108 Communicated by Philip Needleman, Monsanto Company, St. Louis, MO, November 21, 2000 (received for review July 27, 2000) Cyclooxygenase-2 (COX-2), a prostanoid-synthesizing enzyme that 29). In rodents as in humans, cerebral ischemia up-regulates contributes to the toxicity associated with inflammation, has COX-2 in neurons, blood vessels, and inflammatory cells infil- recently emerged as a promising therapeutic target for several trating the injured brain (27, 28, 30). However, experimental illnesses, ranging from osteoarthritis to Alzheimer’s disease. Al- evidence linking COX-2 to the mechanisms of brain injury though COX-2 has also been linked to ischemic stroke, its role in the associated with these conditions is lacking. For example, al- mechanisms of ischemic brain injury remains controversial. We though it is well established that cerebral ischemia increases demonstrate that COX-2-deficient mice have a significant reduc- COX-2 expression in the damaged brain, studies using COX tion in the brain injury produced by occlusion of the middle inhibitors in models of focal cerebral ischemia have yielded cerebral artery. The protection can be attributed to attenuation conflicting results (28, 31, 32). Furthermore, studies using of glutamate neurotoxicity, a critical factor in the initiation of COX-2 inhibitors cannot exclude effects unrelated to COX-2, ischemic brain injury, and to abrogation of the deleterious effects of postischemic inflammation, a process contributing to the sec- such as modification of gene expression or activation of perox- ondary progression of the damage.
    [Show full text]
  • Impact of an Immune Modulator Fingolimod on Acute Ischemic Stroke
    Impact of an immune modulator fingolimod on acute ischemic stroke Ying Fua,b, Ningnannan Zhangc, Li Rena, Yaping Yana, Na Suna, Yu-Jing Lia, Wei Hanc, Rong Xuea, Qiang Liua,b, Junwei Haoa, Chunshui Yuc, and Fu-Dong Shia,b,d,1 Departments of aNeurology and cRadiology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, 300070, China; bDepartment of Neurology, Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, Phoenix, AZ 85013; and dDepartment of Immunology, Tianjin Medical University, Tianjin, 300070, China Edited by Solomon H. Snyder, The Johns Hopkins University School of Medicine, Baltimore, MD, and approved November 5, 2014 (received for review August 21, 2014) Peripheral lymphocytes entering brain ischemic regions orches- brain (7, 8). Cell types most frequently known to enter the brain + + trate inflammatory responses, catalyze tissue death, and worsen during AIS belong to the CD4 T-cell, CD8 T-cell, neutrophil, clinical outcomes of acute ischemic stroke (AIS) in preclinical and macrophage, and natural killer (NK) cell subpopulations. studies. However, it is not known whether modulating brain Such cells, as infiltrate within the peri-infarcted areas of brain inflammation can impact the outcome of patients with AIS. In this tissues from AIS patients (9, 10), become intimately involved in open-label, evaluator-blinded, parallel-group clinical pilot trial, we all stages of the ischemic cascade (7, 8). Studies in experimental recruited 22 patients matched for clinical and MRI characteristics, stroke have indicated that all these cells contribute to the death with anterior cerebral circulation occlusion and onset of stroke of ischemic neurons by promoting focal inflammatory reactions, that had exceeded 4.5 h, who then received standard manage- direct killing, triggering of antigen-specific immune responses, or ment alone (controls) or standard management plus fingolimod alterations in neuronal excitability (6, 10–12).
    [Show full text]
  • Guidelines for Performance, Interpretation, and Application of Stress Echocardiography in Ischemic Heart Disease: from the American Society of Echocardiography
    GUIDELINES AND STANDARDS Guidelines for Performance, Interpretation, and Application of Stress Echocardiography in Ischemic Heart Disease: From the American Society of Echocardiography Patricia A. Pellikka, MD, FASE, Chair, Adelaide Arruda-Olson, MD, PhD, FASE, Farooq A. Chaudhry, MD, FASE,* Ming Hui Chen, MD, MMSc, FASE, Jane E. Marshall, RDCS, FASE, Thomas R. Porter, MD, FASE, and Stephen G. Sawada, MD, Rochester, Minnesota; New York, New York; Boston, Massachusetts; Omaha, Nebraska; Indianapolis, Indiana Keywords: Echocardiography, Stress, Guidelines, Imaging, Ischemic heart disease, Stress test, Pediatrics This document is endorsed by the following ASE International Alliance Partners: Argentine Federation of Cardiology, Argentine Society of Cardiology, ASEAN Society of Echocardiography, Association of Echocardiography and Cardiovascular Imaging of the Interamerican Society of Cardiology, Australasian Sonographers Association, Canadian Society of Echocardiography, Chinese Society of Echocardiography, Cuban Society of Cardiography Echocardiography Section, Department of Cardiovascular Imaging of the Brazilian Society of Cardiology, Indian Academy of Echocardiography, Indian Association of Cardiovascular Thoracic Anaesthesiologists, Indonesian Society of Echocardiography, Iranian Society of Echocardiography, Israeli Working Group on Echocardiography, Italian Association of CardioThoracic and Vascular Anaesthesia and Intensive Care, Japanese Society of Echocardiography, Korean Society of Echocardiography, Mexican Society of Echocardiography
    [Show full text]
  • 1 Ischemic Cascade
    New clinical pathway for chest pain assessment: Role of Cardiac MDCT Ischemic Cascade Ischemia Angina Treadmill test ECG change (TMT) Systolic Dysfunction Stress functional Diastolic Dysfunction (Echo, MRI) Sang Il Choi, M.D. ([email protected]) Transmural Hypoperfusion Stress perfusion Assistant Professor Subendocardial Hypoperfusion (SPECT, MRI) Director of CT and 3D Imaging lab Department of Diagnostic Radiology Seoul National University Bundang Hospital Time College of Medicine Seoul National University Potential clinical application Potential clinical application Sudden Death • Atypical, symptomatic, chest pain Angina • Chest pain with equivocal stress test Symptoms Cardiac Exclusion/Presence • Preprocedural evaluation of chronic total occlusion CT of Clinical Disease • Acute coronary syndrome Cardiac Pre-Clinical Disease • Preoperative evaluation of coronary artery bypass High Risk CT Wall Changes graft or non-cardiac surgery at high risk patients • Evaluation of stent patency • Normal variation and congenital anomaly Low Risk • Asymptomatic patient for screening Prevent Medical Therapy MI Fayad et al, Circulation 2002 MDCT in Atypical Chest Pain MDCT in Atypical Chest Pain • Significant number of noncardiac findings in cardiac MDCT: (M/61) Chest pain: continuous, radiating to the back - new, noncaridac findings: 292/346 patients (58.1%) TMT and Holter: Normal EchoCG: Normal - clinically significant findings: 114/346 patients (22.7%) SPECT: Fixed defect at anterior wall (R/O Breast attenuation) Onuma Y. JACC 2006; 04.071v1.
    [Show full text]
  • Manipulation of the Microbiome and Its Impact on Functional Recovery Following Ischemic Stroke Michal Jandzinski [email protected]
    University of Connecticut OpenCommons@UConn Honors Scholar Theses Honors Scholar Program Spring 5-1-2015 Manipulation of the Microbiome and Its Impact on Functional Recovery Following Ischemic Stroke Michal Jandzinski [email protected] Follow this and additional works at: https://opencommons.uconn.edu/srhonors_theses Part of the Biochemical Phenomena, Metabolism, and Nutrition Commons, Biology Commons, Medical Microbiology Commons, Neurosciences Commons, Other Cell and Developmental Biology Commons, Other Immunology and Infectious Disease Commons, and the Systems and Integrative Physiology Commons Recommended Citation Jandzinski, Michal, "Manipulation of the Microbiome and Its Impact on Functional Recovery Following Ischemic Stroke" (2015). Honors Scholar Theses. 414. https://opencommons.uconn.edu/srhonors_theses/414 Manipulation of the Microbiome and Its Impact on Functional Recovery Following Ischemic Stroke Michal Jandzinski University of Connecticut, 2015 We are all covered from head to toe, internally and externally, by trillions of microbes without even realizing it. Who are these microscopic neighbors of ours? How did they come to inhabit every square inch of our bodies? What purpose do they serve? These are all questions that this paper will seek to explore and answer in the background section. Following the discussion, the background knowledge will be applied to a completely novel area of research: how the microbiome impacts ischemic stroke. 1 Background Trends exist all over the world in all sorts of things. As of
    [Show full text]
  • Neuroinflammation After Acute Ischemic Stroke: a Volcano Hard to Contain
    中国现代神经疾病杂志 年 月第 卷第 期 · 964 · 2013 11 13 11 Chin J Contemp Neurol Neurosurg, November 2013, Vol. 13, No. 11 Reviews · · Neuroinflammation after acute ischemic stroke: a volcano hard to contain Monika Mishra, Vishnumurthy Shushrutha Hedna Department of Neurology, College of Medicine, University of Florida, Gainesville, Florida, USA Keywords Brain ischemia; Inflammation; Central Abstract nervous system; Immunity, celluar; Many endogenous, exogenous and systemic factors individually can lead Neuroimmunomodulation; Review. to occlusive vessel pathology affecting the neuroendovascular unit 【关键词】 脑缺血; 炎症; 中枢神经 compromising cerebral blood flow. The brain ischemia thus created 系 统 ; 免 疫 ,细胞 ; 神 经 免 疫 调 节 ; irrespective of the pathology has similar endpoint and involves blood 综述 vessels, astrocytes, neurons and surrounding microglia triggering the whole spectrum of neuroinflammation which is an important component Correspondence in the ischemic cascade. The resultant series of neuroinflammatory Vishnumurthy Shushrutha Hedna, Assistant reactions cause depolarization of neuronal cells and activation of pro Professor, Department of Neurology ⁃ inflammatory cellular agents and subsequently cell death. Room L3-100, McKnight Brain Institute Neuroinflammation can be an effect and (or) cause of acute energy failure, 1149 Newell Drive, Gainesville, FL 32611 excitotoxicity, ionic imbalance, channel dysfunctions, and oxidative free Tel: +11 352 273 5550 radicals in the central nervous system. Non restoration of the blood flow Fax: +11 352 273 5575 ⁃ Email: [email protected] within the threshold period can result in an extensive brain damage from activation of deadly latent proteases like matrix metalloprotease, and Received: 11 August, 2013. immediate early genes destroying the neuronal microenvironment and blood brain barrier.
    [Show full text]
  • Role of Herbal Teas in Regulating Cellular Homeostasis and Autophagy and Their Implications in Regulating Overall Health
    nutrients Review Role of Herbal Teas in Regulating Cellular Homeostasis and Autophagy and Their Implications in Regulating Overall Health James Michael Brimson 1,2 , Mani Iyer Prasanth 1,2, Dicson Sheeja Malar 1,2, Rajasekharan Sharika 3, Bhagavathi Sundaram Sivamaruthi 4, Periyanaina Kesika 4 , Chaiyavat Chaiyasut 4 , Tewin Tencomnao 1,2,* and Anchalee Prasansuklab 1,5,* 1 Natural Products for Neuroprotection and Anti-Ageing Research Unit, Chulalongkorn University, Bangkok 10330, Thailand; [email protected] (J.M.B.); [email protected] (M.I.P.); [email protected] (D.S.M.) 2 Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand 3 Department of Transfusion Medicine and Clinical Microbiology, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand; [email protected] 4 Innovation Center for Holistic Health, Nutraceuticals, and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand; [email protected] (B.S.S.); [email protected] (P.K.); [email protected] (C.C.) 5 College of Public Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand * Correspondence: [email protected] (T.T.); [email protected] (A.P.) Citation: Brimson, J.M.; Prasanth, M.I.; Malar, D.S.; Sharika, R.; Abstract: Tea is one of the most popular and widely consumed beverages worldwide, and possesses Sivamaruthi, B.S.; Kesika, P.; numerous potential health benefits. Herbal teas are well-known to contain an abundance of polyphe- Chaiyasut, C.; Tencomnao, T.; nol antioxidants and other ingredients, thereby implicating protection and treatment against various Prasansuklab, A. Role of Herbal Teas ailments, and maintaining overall health in humans, although their mechanisms of action have not in Regulating Cellular Homeostasis yet been fully identified.
    [Show full text]